Prostate Cancer

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


WHO WE ARE — Seattle Cancer Care Alliance is a world-class cancer treatment center that unites doctors from Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Children's. Learn More

Overview

If you have been diagnosed with prostate cancer, there are a lot of things to think about before embarking upon a treatment. Become informed about the options, and seek a second opinion if you have concerns along the way, because there are many opinions about how to treat prostate cancer.

Prostate cancer can be a complex disease to treat. Studies have shown that the first treatment you receive for cancer is by far the most important. On average, prostate cancer patients who begin their treatment at Seattle Cancer Care Alliance have better survival rates than those who started treatment elsewhere. Our broad array of treatment options reflects our intensive and successful efforts to treat and cure patients with minimal side effects.

Our doctors specialize in prostate and genitourinary cancer and do not treat any other cancers. They are nationally renowned experts in treating your specific disease.  Our team of medical oncologists, radiation oncologists, and surgeons work together to provide customized treatments for each patient.

Just Diagnosed? Get a Second Opinion

Get a Second Opinion Getting a second opinion is more than a formality. It’s an essential way to verify stage, location--even the existence of your cancer. A second opinion may also provide access to potentially new treatments or clinical trials that are available. Get a second opinion at SCCA.

SCCA has in its arsenal the latest in prostate cancer treatment, from laparoscopic da Vinci robotic surgery to proton therapy at SCCA Proton Therapy, A ProCure Center. In addition, tomorrow's treatments are available to patients who elect to take part in one of several dozen clinical trials that are available only at SCCA and selected sites around the country.

SCCA received a Specialized Program of Research Excellence (SPORE) grant for our prostate cancer science expertise and a Department of Defense (DOD) Clinical Trials Consortium grant for our clinical studies expertise. The SPORE grant was awarded to only 11 institutions around the country and the DOD grant to only 13 institutions. SCCA is one of only five institutions with both of these important research grants currently funded, a testament to our expertise and dedication to treating and curing prostate cancer.